Page last updated: 2024-10-26
ethyl loflazepate and Chronic Kidney Failure
ethyl loflazepate has been researched along with Chronic Kidney Failure in 1 studies
ethyl loflazepate: structure given in first source
Research Excerpts
Excerpt | Relevance | Reference |
---|---|---|
" In contrast, elimination half-life and total plasma clearance of the sum of loflazepate + descarboxyloflazepate seemed to be independent of the degree of renal impairment." | 1.28 | Effect of renal failure on the pharmacokinetics of ethyl loflazepate (Victan) in man. ( Ba, BB; Berger, Y; Cano, JP; Durand, A; Iliadis, A; Necciari, J, 1989) |
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Ba, BB | 1 |
Iliadis, A | 1 |
Durand, A | 1 |
Berger, Y | 1 |
Necciari, J | 1 |
Cano, JP | 1 |
Other Studies
1 other study available for ethyl loflazepate and Chronic Kidney Failure
Article | Year |
---|---|
Effect of renal failure on the pharmacokinetics of ethyl loflazepate (Victan) in man.
Topics: Administration, Oral; Adult; Aged; Anti-Anxiety Agents; Benzodiazepines; Benzodiazepinones; Female; | 1989 |